Mar 01, 2019 / Chapters

Executive summary (March 2019 report)

Research Areas:

Beneficiaries and Coverage, Delivery System Reforms, Drugs, Devices, and Tests, Hospitals, Physicians And Other Health Professionals, Post-Acute Care, Private Plans, Quality, Regional Issues

Jan 18, 2019 / Presentations

Future policy directions to address Medicare prescription drug spending

Research Areas:

Drugs, Devices, and Tests

Jan 17, 2019 / Presentations

The Medicare prescription drug program (Part D): Status report

Research Areas:

Drugs, Devices, and Tests, Private Plans

Jan 16, 2019 / Comment Letters

MedPAC comment on CMS’s proposed rule on modernizing Part D and Medicare Advantage to lower drug prices and reduce OOP expenses

Research Areas:

Delivery System Reforms, Drugs, Devices, and Tests, Private Plans

Nov 28, 2018 / Comment Letters

MedPAC comment on CMS’s proposed rule on requiring drug pricing transparency

Research Areas:

Delivery System Reforms, Drugs, Devices, and Tests

Nov 01, 2018 / Presentations

Promoting greater Medicare-Medicaid integration in dual-eligible special-needs plans

Research Areas:

Drugs, Devices, and Tests, Private Plans

Oct 04, 2018 / Presentations

Managing prescription opioid use in Medicare Part D

Research Areas:

Drugs, Devices, and Tests, Private Plans

Oct 04, 2018 / Presentations

Opioids and alternatives in hospital settings: Payments, incentives, and Medicare data

Research Areas:

Drugs, Devices, and Tests, Hospitals

Sep 06, 2018 / Presentations

Beneficiary enrollment in Medicare

Research Areas:

Beneficiaries and Coverage

Aug 31, 2018 / Comment Letters

MedPAC comment on CMS’s proposed rule on the ESRD PPS update for CY 2019 and DMEPOS Competitive Bidding Program

Research Areas:

Ambulatory Care Settings, Delivery System Reforms, Drugs, Devices, and Tests, Quality